AbbVie Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $84.95B | $13.08B | $8.45B |
| FY2021 | $75.96B | $15.41B | $9.75B |
| FY2022 | $63.13B | $17.25B | $9.20B |
| FY2023 | $59.25B | $10.36B | $12.81B |
| FY2024 | $66.84B | $3.33B | $5.52B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $84.95B | $13.08B | $8.45B |
| FY2021 | $75.96B | $15.41B | $9.75B |
| FY2022 | $63.13B | $17.25B | $9.20B |
| FY2023 | $59.25B | $10.36B | $12.81B |
| FY2024 | $66.84B | $3.33B | $5.52B |